Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06718972

A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China

Database of Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Guangzhou Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a retrospective and prospective study planned to include NSCLC patients with Leptomeningeal metastasis (LM) and treated with antitumor therapy after 2018, from multiple centers such as the First Affiliated Hospital of Guangzhou Medical University, Guangdong Sanjiu Brain Hospital, etc., aiming to establish a database related to the treatment strategies of LM patients, and to evaluate the efficacy (eg. Overall Survival/Time to Failure) and safety of different treatment strategies of LM patients, etc., as well as the significance of concomitant testing in LM patients.

Detailed description

retrospective and prospective study

Conditions

Interventions

TypeNameDescription
OTHERNot applicable- observational studyThis is a retrospective and observational study. Not Applicable

Timeline

Start date
2024-09-01
Primary completion
2028-12-31
Completion
2028-12-31
First posted
2024-12-05
Last updated
2025-04-27

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT06718972. Inclusion in this directory is not an endorsement.

A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China (NCT06718972) · Clinical Trials Directory